Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-003623-23Phase 3Active
Phase 3, randomised trial in schizophrenia and cannabis use disorder (CUD) comparing Clozapine with Risperidone (2 arms). Primary endpoints: Craving-related functional brain activity and Subjective cannabis craving. Started Aug 2008; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-003623-23.